BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 10081875)

  • 21. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.
    De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A
    J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
    Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG
    BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
    Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
    Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
    J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
    Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator: correlation with clinical data of long-term observations.
    Schäfer W; Funke PJ; Kunde D; Rausch U; Wennemuth G; Stützer H
    J Urol; 2006 Aug; 176(2):532-7. PubMed ID: 16813883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
    J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables.
    Lau WK; Bergstralh EJ; Blute ML; Slezak JM; Zincke H
    J Urol; 2002 Jan; 167(1):117-22. PubMed ID: 11743287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant cytological washings from prostate specimens: an independent predictor of biochemical progression after radical prostatectomy.
    Ward JF; Sands JP; Nowacki M; Amling CL
    J Urol; 2001 Feb; 165(2):469-73. PubMed ID: 11176398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
    Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
    BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.